| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Dahiya R and Brasitus TA | Glycosphingolipid patterns of fetal and adult small intestinal mucosa in the sheep. | 1986 | Biochim. Biophys. Acta | pmid:3942764 |
| Sharma R et al. | A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside. | 2003 | Biochim. Biophys. Acta | pmid:12527415 |
| Rosales Fritz VM et al. | Chinese hamster ovary cells lacking GM1 and GD1a synthesize gangliosides upon transfection with human GM2 synthase. | 1997 | Biochim. Biophys. Acta | pmid:9396632 |
| Yadao F et al. | Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A. | 1997 | Biochim. Biophys. Acta | pmid:9217013 |
| Kundu M et al. | Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway. | 2016 | Biochim. Biophys. Acta | pmid:27066976 |
| Novak A et al. | Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate. | 1994 | Biochim. Biophys. Acta | pmid:8123671 |
| Novak A and Lowden JA | GM2 ganglioside activator occurs in multiple forms. | 1994 | Biochim. Biophys. Acta | pmid:8123670 |
| Li YT et al. | Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility. | 2008 | Biochim. Biophys. Acta | pmid:17967427 |
| Itakura T et al. | Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice. | 2006 | Biol. Pharm. Bull. | pmid:16880605 |
| Brown ER and Ibrahim JG | A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. | 2003 | Biometrics | pmid:12926706 |
| Bisel B et al. | GM1 and GM2 gangliosides: recent developments. | 2014 | Biomol Concepts | pmid:25372744 |
| Rapoport E et al. | Ganglioside binding pattern of CD33-related siglecs. | 2003 | Bioorg. Med. Chem. Lett. | pmid:12639556 |
| Beccari T et al. | Promoter characterization and expression of the gene coding for the human GM2 activator protein. | 2001 | Biosci. Rep. | pmid:11508694 |
| Sorice M et al. | Glycosphingolipid domains on cell plasma membrane. | 1999 | Biosci. Rep. | pmid:10513897 |
| Nojiri H et al. | Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60. | 1984 | Blood | pmid:6589019 |
| Kohyama M et al. | In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses. | 2016 | BMC Vet. Res. | pmid:27036194 |
| Milnik A et al. | Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma. | 2013 | BMJ Case Rep | pmid:23341581 |
| Lichtenberg P et al. | Post-partum psychosis in adult GM2 gangliosidosis. A case report. | 1988 | Br J Psychiatry | pmid:2977954 |
| Hanisch FG et al. | Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential. | 1990 | Br. J. Cancer | pmid:2372482 |
| Sakuraba H et al. | Prenatal diagnosis of GM2-gangliosidosis. Immunofluorescence analysis of ganglioside GM2 in cultured amniocytes by confocal laser scanning microscopy. | Brain Dev. | pmid:8250149 | |
| Taniguchi M et al. | Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain. | 2001 | Brain Dev. | pmid:11578853 |
| Sato M et al. | Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone: an implication for the basic defect in Niemann-Pick disease type C. | 1998 | Brain Dev. | pmid:9533562 |
| Wenger DA | Diagnosis of atypical patients with lipid storage diseases. | 1985 | Brain Dev. | pmid:4014607 |
| Itoh H et al. | The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. | 1984 | Brain Dev. | pmid:6097133 |
| Watanabe Y et al. | Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann-Pick disease type C. | 1998 | Brain Dev. | pmid:9545179 |
| Yu RK et al. | Characterization of some minor gangliosides in Tay-Sachs brains. | 1983 | Brain Res. | pmid:6414648 |
| Purpura DP and Suzuki K | Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. | 1976 | Brain Res. | pmid:824017 |
| Hoffman LM et al. | GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease. | 1976 | Brain Res. | pmid:953690 |
| Trilck M et al. | Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons. | 2017 | Brain Res. | pmid:27923633 |
| Yoshino H et al. | Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves. | 2008 | Brain Res. | pmid:18598683 |
| Crawley AC et al. | Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. | 2006 | Brain Res. | pmid:16828069 |
| Goodman LA and Walkley SU | Elevated GM2 ganglioside is associated with dendritic proliferation in normal developing neocortex. | 1996 | Brain Res. Dev. Brain Res. | pmid:8804703 |
| Kyrkanides S et al. | beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration. | 2005 | Brain Res. Mol. Brain Res. | pmid:15710246 |
| Yuyama Y et al. | Enhanced expression of GM2/GD2 synthase mRNA in human gastrointestinal cancer. | 1995 | Cancer | pmid:7533654 |
| Miyake M et al. | The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies. | 1990 | Cancer | pmid:2153431 |
| Livingston PO et al. | Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy. | 2005 | Cancer Immunol. Immunother. | pmid:15926079 |
| Zhao Y et al. | Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody. | 2007 | Cancer Immunol. Immunother. | pmid:16896968 |
| Parajuli P et al. | Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients. | 2001 | Cancer Lett. | pmid:11275367 |
| Natoli EJ et al. | A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. | 1986 | Cancer Res. | pmid:3731079 |
| Retter MW et al. | Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. | 2005 | Cancer Res. | pmid:16024647 |
| Higashi H et al. | Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. | 1985 | Cancer Res. | pmid:3874688 |
| Nakamura K et al. | Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody. | 1999 | Cancer Res. | pmid:10537316 |
| Nishinaka Y et al. | Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment. | 1996 | Cancer Res. | pmid:8971173 |
| Helling F et al. | GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. | 1995 | Cancer Res. | pmid:7796403 |
| Yoshida S et al. | Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. | 2001 | Cancer Res. | pmid:11358851 |
| Nakamura K et al. | Chimeric anti-ganglioside GM2 antibody with antitumor activity. | 1994 | Cancer Res. | pmid:8137257 |
| Yamashiro S et al. | Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. | 1993 | Cancer Res. | pmid:8221677 |
| Bjerkvig R et al. | Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line. | 1991 | Cancer Res. | pmid:1873810 |
| Livingston PO et al. | Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. | 1989 | Cancer Res. | pmid:2582446 |
| Vrionis FD et al. | Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines. | 1989 | Cancer Res. | pmid:2479468 |
| Miyake M et al. | Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. | 1988 | Cancer Res. | pmid:3167861 |
| Biswas K et al. | GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction. | 2006 | Cancer Res. | pmid:16818659 |
| Yin J et al. | Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. | 2006 | Cancer Res. | pmid:16540641 |
| Li Q et al. | Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma. | 2015 | Cancer Sci. | pmid:25421609 |
| Yamada T et al. | Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells. | 2011 | Cancer Sci. | pmid:21895875 |
| Sugimoto M et al. | Total synthesis of gangliosides GM1 and GM2. | 1986 | Carbohydr. Res. | pmid:3815403 |
| Blixt O et al. | Chemoenzymatic synthesis of 2-azidoethyl-ganglio-oligosaccharides GD3, GT3, GM2, GD2, GT2, GM1, and GD1a. | 2005 | Carbohydr. Res. | pmid:16005859 |
| Larsson EA et al. | Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1. | 2007 | Carbohydr. Res. | pmid:17069778 |
| Ishida H et al. | Synthesis of 6'-GM2, a regioisomer of ganglioside GM2, for studying the mechanism of action of GM2 activator. | 1997 | Carbohydr. Res. | pmid:9291574 |
| Fujita S et al. | Total synthesis of a modified ganglioside, de-N-acetyl GM2. | 1994 | Carbohydr. Res. | pmid:7805050 |
| Schaeper RJ et al. | In vitro biosynthesis of GbOse4Cer (globoside) and GM2 ganglioside by the (1-->3) and (1-->4)-N-acetyl beta-D-galactosaminyltransferases from embryonic chicken brain. Solubilization, purification, and characterization of the transferases. | 1992 | Carbohydr. Res. | pmid:1291049 |
| Kotani M et al. | Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts. | 1994 | Cell Struct. Funct. | pmid:7923401 |
| Zhou J et al. | Gangliosides enhance apoptosis of thymocytes. | 1998 | Cell. Immunol. | pmid:9606992 |
| Macauley MS et al. | Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. | 2010 | Chem. Biol. | pmid:20851344 |
| Fort S et al. | Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli. | 2005 | Chem. Commun. (Camb.) | pmid:15900325 |
| Yamaguchi T et al. | Ganglioside-embedding small bicelles for probing membrane-landing processes of intrinsically disordered proteins. | 2013 | Chem. Commun. (Camb.) | pmid:23296043 |
| Dawson G et al. | Regulation of GM2 ganglioside metabolism in cultured cells. | 1986 | Chem. Phys. Lipids | pmid:3549015 |
| Sasaki T | Glycolipid-binding proteins. | 1985 | Chem. Phys. Lipids | pmid:4064224 |
| Cantù L et al. | Evidence for spontaneous segregation phenomena in mixed micelles of gangliosides. | 1990 | Chem. Phys. Lipids | pmid:2289284 |
| Antoine T et al. | Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. | 2003 | Chembiochem | pmid:12740812 |
| Yin Z et al. | Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies. | 2016 | Chembiochem | pmid:26538065 |
| Dziadek S et al. | A novel linker methodology for the synthesis of tailored conjugate vaccines composed of complex carbohydrate antigens and specific TH-cell peptide epitopes. | 2008 | Chemistry | pmid:18478617 |
| Bay S et al. | Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide. | 2009 | ChemMedChem | pmid:19226501 |
| Vachalová I et al. | Anti-GM2, -GD1a and -GD1b positive purely isolated facial diplegia. | 2014 | Clin Neurol Neurosurg | pmid:24813327 |
| Portoukalian J | Immunogenicity of glycolipids. | 2000 | Clin Rev Allergy Immunol | pmid:11064828 |
| Mahuran DJ et al. | The molecular basis of Tay-Sachs disease: mutation identification and diagnosis. | 1990 | Clin. Biochem. | pmid:2147596 |
| Gu J et al. | Simultaneous quantification of GM1 and GM2 gangliosides by isotope dilution tandem mass spectrometry. | 2008 | Clin. Biochem. | pmid:18241673 |
| Chapman PB et al. | Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin. | 2000 | Clin. Cancer Res. | pmid:11156217 |
| Chapman PB et al. | Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study. | 2000 | Clin. Cancer Res. | pmid:10741710 |
| Krug LM et al. | Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. | 2004 | Clin. Cancer Res. | pmid:14871967 |
| Kuo CT et al. | Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. | 1998 | Clin. Cancer Res. | pmid:9516930 |
| Alvarez-Rueda N et al. | Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. | 2007 | Clin. Cancer Res. | pmid:17875797 |
| Zeigler M and Bach G | Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. | 1986 | Clin. Chim. Acta | pmid:3087662 |
| Charrow J and Binns HJ | Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses. | 1986 | Clin. Chim. Acta | pmid:2938852 |
| Poulos A et al. | Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate. | 1982 | Clin. Chim. Acta | pmid:6210469 |
| Molzer B and Bernheimer H | Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay. | 1976 | Clin. Chim. Acta | pmid:826357 |
| Harzer K | Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses. | 1983 | Clin. Chim. Acta | pmid:6228344 |
| Sakuraba H et al. | Immunocytochemical detection of accumulated substrates in cultured fibroblasts from patients with the infantile and adult forms of Sandhoff disease. | 1997 | Clin. Chim. Acta | pmid:9385467 |
| Sandhoff K and Kolter T | Biochemistry of glycosphingolipid degradation. | 1997 | Clin. Chim. Acta | pmid:9435988 |
| Erzberger A et al. | Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. | 1980 | Clin. Chim. Acta | pmid:6781795 |
| Kawashima I et al. | Cytochemical analysis of storage materials in cultured skin fibroblasts from patients with I-cell disease. | 2007 | Clin. Chim. Acta | pmid:17204262 |
| Tsuji D et al. | Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. | 2007 | Clin. Chim. Acta | pmid:17196574 |
| Wölfl M et al. | Gangliosides inhibit the development from monocytes to dendritic cells. | 2002 | Clin. Exp. Immunol. | pmid:12452834 |
| Hanibuchi M et al. | Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966. | 2000 | Clin. Exp. Metastasis | pmid:11467766 |
| O'Brien JS et al. | Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. | 1977 | Clin. Genet. | pmid:13950 |
| Hechtman P et al. | The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese. | 1989 | Clin. Genet. | pmid:2527097 |
| Kimata H and Yoshida A | Inhibition of spontaneous immunoglobulin production by ganglioside GM2 in human B cells. | 1996 | Clin. Immunol. Immunopathol. | pmid:8620627 |
| Sakuraba H et al. | Molecular pathologies of and enzyme replacement therapies for lysosomal diseases. | 2006 | CNS Neurol Disord Drug Targets | pmid:16918392 |
| Hovakimyan M et al. | Morphological alterations of the cornea in the mouse model of niemann-pick disease type c1. | 2011 | Cornea | pmid:21317782 |
| Jones PC and Irie RF | Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions. | 2016 | Crit Rev Oncog | pmid:27481004 |
Ganglioside GM2
Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.
Cross Reference
Introduction
To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Ganglioside GM2?
Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Ganglioside GM2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Ganglioside GM2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Ganglioside GM2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Ganglioside GM2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Ganglioside GM2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Ganglioside GM2?
Disease model
Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.